What are the specific experimental steps of DARTS? Should mass spectrometry be performed after staining or has the target protein been found and used for validation? After staining, many proteins have changed. How should mass spectrometry samples be sent?

The basic steps of DARTS technology mainly include:

 

1. Sample preparation:

Mix the drug to be tested with the protein in the cell lysis buffer or tissue extract, and incubate for a period of time.

 

2. Protein digestion:

After a period of time, add protease (usually trypsin) for partial digestion.

 

3. Gel electrophoresis:

Perform SDS-PAGE analysis on the digested samples to separate protein fragments of different sizes.

 

4. Mass spectrometry analysis:

Cut the protein bands after electrophoresis, usually selecting bands that show significant differences compared to the control group, and then perform mass spectrometry analysis to identify the proteins in these bands.

 

In the DARTS technology process, mass spectrometry analysis can occur before or after staining, depending on your experimental objectives:

1. Direct mass spectrometry analysis from unstained gel slices:

• This method is the standard operating procedure, aimed at directly identifying potential drug target proteins from the DARTS experiment. In this case, proteins are separated by SDS-PAGE, and the bands containing potential target proteins are directly cut from the unstained gel for mass spectrometry analysis. The benefit of this approach is that it avoids chemical contamination that may arise from staining, ensuring the accuracy and sensitivity of the mass spectrometry analysis.
• At this step, mass spectrometry analysis is used to identify proteins that exhibit different stabilities in the presence and absence of the drug. These proteins show higher stability during enzyme treatment due to their binding with the drug.

 

2. Further verification with mass spectrometry after staining:

• In certain cases, Coomassie Blue staining can be performed first to visualize the distribution of the entire protein sample, and then specific protein bands can be selected for slicing and mass spectrometry analysis. This is usually done after preliminary data indicating which proteins may be drug targets are available. Staining helps to verify and optimize experiments, especially in terms of the efficiency of protein extraction and digestion steps.
• Although mass spectrometry analysis after staining may have some technical challenges (such as dye residues potentially interfering with mass spectrometry signals), modern protein purification and elution techniques are sufficient to overcome these challenges, making proteins extracted from stained gels still suitable for high-quality mass spectrometry analysis.

 

As for the situation of multiple protein changes discovered after staining, this suggests that multiple proteins may respond to the drug. In this case, proteins that show significant stability changes in the drug treatment group (such as bands that are more pronounced or proteins that are less digested) should be selected for mass spectrometry analysis. This allows for a more targeted identification of potential target proteins that interact directly with the drug.

 

Baitai Paike Biotechnology--Characterization of biological products, providing high-quality service for multi-group biomicroscopy detection

 

Related services:

Identification and validation of small molecule drug targets

Analysis of PROTAC drug off-targets

Mass spectrometry analysis of protein interactions